Declaration of Dividend for the financial year 2025-26
SMSPHARMA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
SMS Pharmaceuticals has declared a final dividend of Rs. 0.40 per equity share (40%) for FY 2025-26, subject to shareholder approval at the ensuing AGM. The company reported strong financial performance with standalone net profit up 28% to Rs. 8,760.93 lakhs and consolidated net profit up 47.5% to Rs. 10,198.91 lakhs compared to the previous year. Consolidated revenue grew 13% to Rs. 89,522.48 lakhs. The board also approved shifting the registered office within Hyderabad city limits and made auditor appointments for FY 2026-27.
The dividend declaration signals financial stability and rewards shareholders, though the 40% payout is consistent with prior year (Rs. 354.61 lakhs dividend paid). The strong profit growth without a corresponding dividend increase suggests retained earnings for funding expansion plans.